Preliminary Study of Prognosis of Patients with Hypertensive Intracerebral Hemorrhage by Improving Per-i-hematomal Ischemia

Qiang DONG,Ren-Liang ZHANG,Xiang HAN,Chuan-Zhen LU,Dan HE
DOI: https://doi.org/10.3969/j.issn.1008-0678.2000.04.010
2000-01-01
Abstract:Aim: To evaluate the effects of the drugs dextran Iow molecular and Xueshuantong,which can improve peri-hematomal ischemia on the volumes of hematoma and edema, and the neurological function in the patients withICH. Methods:21 patients with ICH were at random divided into 3 groups. The volumes of hematoma and edema were mea-sured by CT,ESS/CSS were assessed separately. Results: (1)The volume of hematoma was reduced markedly in the treatmentgroups in 10 days after administration. (2)In the group of dextran low molecular,the volume of edema was decreasing in the4,10,21 day after treatment. (3)There is an obvious correlation between the ESS/CSS and the volumes of hematoma and ede-ma. (4)After treatment,ESS/CSS can be improved in the group of dextran low nolecular in 4,10,21 day,and ESS/CSS canalso be improved in the group of Xueshuantong in 21 day. Conclusion:Dextran Iow molecular and Xueshuantong can improveperi-hematomal ischemia,absorption of hematoma,reducing the edema and recovering the neurological function in the patientwith ICH.
What problem does this paper attempt to address?